Milsoul-FM Tablet

Prescription Required
Marketer: Dr D SANTE LIFESCIENCES
Salt Composition: Flupentixol (0.5mg), Melitracen (10mg)
Storage: Store below 30°C. Protect from moisture.

📌 PRODUCT INTRODUCTION

Milsoul-FM Tablet is a fixed-dose psychotropic combination that treats mild-to-moderate depression, anxiety, and psychosomatic symptoms. It is particularly effective in patients with somatic complaints like fatigue, body pain, or sleep disturbances where psychological distress underlies physical symptoms.

💊 PHARMACOLOGICAL CLASS

  • Flupentixol: Typical antipsychotic (low-dose), dopamine D1/D2 receptor antagonist
  • Melitracen: Tricyclic antidepressant (TCA), norepinephrine and serotonin reuptake inhibitor

🩺 CLINICAL USES

  • Mixed anxiety-depression disorders
  • Stress-related physical complaints (headaches, IBS)
  • Menopausal mood instability
  • Non-psychotic dysthymia
  • Chronic fatigue syndrome

🌟 BENEFITS

  • Combats both mental and physical symptoms of anxiety and depression
  • Improves energy, motivation, and sleep quality
  • Rapid onset of antidepressant effect (usually within 1 week)
  • Well-tolerated and useful in elderly or somatizing patients

⚙️ MECHANISM OF ACTION

  • Flupentixol at low dose mildly stimulates dopamine pathways in the frontal cortex, improving mood and alertness.
  • Melitracen enhances central monoaminergic activity (serotonin & norepinephrine), elevating mood and reducing anxiety.

🔄 DIRECTIONS FOR USE

  1. Start with 1 tablet in the morning.
  2. Maximum dose is 2–3 tablets daily, based on clinical response.
  3. Avoid abrupt discontinuation without physician advice.

⚠️ MAJOR SIDE EFFECTS

  • Akathisia, restlessness, or dyskinesia (rare at low dose)
  • Manic switching in bipolar disorder
  • Prolonged QT (with overdose)

🧾 MINOR SIDE EFFECTS

  • Mild dry mouth
  • Increased sweating
  • Sleep disturbances or vivid dreams
  • Mild weight gain

🚨 WARNINGS & PRECAUTIONS

  • Not for use in manic depression or patients with seizure disorders
  • Caution in elderly and those with cardiovascular disease
  • Avoid alcohol; may enhance sedative effects
  • Monitor for mood swings or suicidal ideation in initial weeks